ONKURE THERAPEUTICS INC-A (OKUR) Stock Income Statement
NASDAQ:OKUR - Nasdaq - US68277Q1058 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 61.82M | 54.39M | 83.05M | 53.85M | 39.82M | |||
| Research and Development | 51.87M | 43.80M | 56.61M | 37.71M | 28.17M | |||
| Selling, General, and Administrative Expenses | 9.96M | 10.59M | 26.44M | 16.14M | 11.65M | |||
| Operating Income | -61.82M | -54.39M | -83.05M | -53.85M | -39.82M | |||
| Interest Income/Expense | N/A | 1.71M | N/A | N/A | N/A | |||
| Other Income/Expense | N/A | N/A | 5.67M | 1.89M | 50.00K | |||
| Income Before Taxes | -60.17M | -52.67M | -77.39M | -51.96M | -39.77M | |||
| Net Income | -60.17M | -52.67M | -77.39M | -51.96M | -39.77M | |||
| EBITDA | -60.97M | -53.72M | -82.88M | -53.76M | -39.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -13.26 | -15.28 | -25.23 | -2.12 | -1.63 | |||
| Non GAAP EPS | -5.26 | -6.57 | -2.53 | -2.12 | -4.86 | |||
| Statistics | ||||||||
All data in USD